Skip to Main Content

Author Details

Jun S Wei
Center for Cancer Research, National Cancer Institute
2001
84
40
PMIDPaper TitleJournal TitlePublished Year
37688579Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.J Natl Cancer Inst2024
37688579Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival.J Natl Cancer Inst2024
36346688Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.Clin Cancer Res2023
36346688Predicting Molecular Subtype and Survival of Rhabdomyosarcoma Patients Using Deep Learning of H&E Images: A Report from the Children's Oncology Group.Clin Cancer Res2023
37627061Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.Cancers (Basel)2023
36773602Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma.Cell Rep Med2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36607839A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.Blood Adv2023
37627061Preclinical Evaluation of the FGFR-Family Inhibitor Futibatinib for Pediatric Rhabdomyosarcoma.Cancers (Basel)2023
36747619Germline pathogenic variants in 786 neuroblastoma patients.medRxiv2023
36607839A stem cell epigenome is associated with primary nonresponse to CD19 CAR T cells in pediatric acute lymphoblastic leukemia.Blood Adv2023
36773602Genomic and transcriptomic analyses identify a prognostic gene signature and predict response to therapy in pleural and peritoneal mesothelioma.Cell Rep Med2023
35465663Dentithecamides A-H, Diacylated Zoanthoxanthin Derivatives with PAX3-FOXO1 Inhibitory Activity from the Hydroid <i>Dentitheca habereri</i>.J Nat Prod2022
35465663Dentithecamides A-H, Diacylated Zoanthoxanthin Derivatives with PAX3-FOXO1 Inhibitory Activity from the Hydroid <i>Dentitheca habereri</i>.J Nat Prod2022
34162872Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.Nat Commun2021
35464627Exploring and Targeting the Tumor Immune Microenvironment of Neuroblastoma.J Cell Immunol2021
34166060Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.J Clin Oncol2021
33848478Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.Cancer Cell2021
34162872Notch signaling and efficacy of PD-1/PD-L1 blockade in relapsed small cell lung cancer.Nat Commun2021
33520712Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.Front Oncol2021
33836455Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma.Cancer Genet2021
33504652Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.Sci Transl Med2021
34661178Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> Gene.JTO Clin Res Rep2021
34610968Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.Cancer Res2021
34836971BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.Nat Commun2021
34485806Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in Glioblastoma.JCO Precis Oncol2021
34885201Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.Cancers (Basel)2021
34818552Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.Cell Rep2021
35464627Exploring and Targeting the Tumor Immune Microenvironment of Neuroblastoma.J Cell Immunol2021
33520712Case Report: Single-Cell Transcriptomic Analysis of an Anaplastic Oligodendroglioma Post Immunotherapy.Front Oncol2021
33848478Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress.Cancer Cell2021
33504652Whole-exome sequencing reveals germline-mutated small cell lung cancer subtype with favorable response to DNA repair-targeted therapies.Sci Transl Med2021
33836455Ataxia telangiectasia mutated germline pathogenic variant in adrenocortical carcinoma.Cancer Genet2021
34885201Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.Cancers (Basel)2021
34818552Immuno-transcriptomic profiling of extracranial pediatric solid malignancies.Cell Rep2021
34610968Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.Cancer Res2021
34661178Phase 2 Study of Olaparib in Malignant Mesothelioma and Correlation of Efficacy With Germline or Somatic Mutations in <i>BAP1</i> Gene.JTO Clin Res Rep2021
34485806Report of Canonical <i>BCR</i>-<i>ABL1</i> Fusion in Glioblastoma.JCO Precis Oncol2021
34836971BAF complexes drive proliferation and block myogenic differentiation in fusion-positive rhabdomyosarcoma.Nat Commun2021
34166060Genomic Classification and Clinical Outcome in Rhabdomyosarcoma: A Report From an International Consortium.J Clin Oncol2021
32483558Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.Cell Rep Med2020
32416589Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage.iScience2020
32060262CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.Nat Commun2020
31783178Anaplastic Lymphoma Kinase Gene Rearrangement in Children and Young Adults With Mesothelioma.J Thorac Oncol2020
32152202Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2.Clin Cancer Res2020
32483558Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer.Cell Rep Med2020
32464188Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers: Results From a Retrospective Multicenter Cohort Study.Chest2020
33028646Dynamics of genomic and immune responses during primary immunotherapy resistance in mismatch repair-deficient tumors.Cold Spring Harb Mol Case Stud2020
32796005Somatic structural variation targets neurodevelopmental genes and identifies <i>SHANK2</i> as a tumor suppressor in neuroblastoma.Genome Res2020
32060262CASZ1 induces skeletal muscle and rhabdomyosarcoma differentiation through a feed-forward loop with MYOD and MYOG.Nat Commun2020
  • 1 - 50 of 168

Recommended Authors

Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 25
David J H Shih
University of Texas MD Anderson Cancer Center Houston
Career Start Year 2009
Number of shared co-authors 16
Sander R van Hooff
Princess Maxima Center for Pediatric Oncology
Career Start Year 2008
Number of shared co-authors 1
Adrian M Dubuc
Dana-Farber Cancer Institute
Career Start Year 2008
Number of shared co-authors 19
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 42
Ritu Roy
University of California San Francisco.
Career Start Year 2007
Number of shared co-authors 3
Roel G W Verhaak
Yale School of Medicine
Career Start Year 2004
Number of shared co-authors 25
Jianhua Zhang
University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 18
Michelle J Henderson
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2002
Number of shared co-authors 11
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 24
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 13
Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Career Start Year 2001
Number of shared co-authors 34
Xiang Chen
St. Jude Children's Research Hospital
Career Start Year 1999
Number of shared co-authors 21
Robert L Walker
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 1997
Number of shared co-authors 28
Donald W Parsons
Texas Children's Hospital
Career Start Year 1996
Number of shared co-authors 28
Stefan Fr??hling
German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT)
Career Start Year 1996
Number of shared co-authors 10
David Cogdell
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 1
Agnes Viale
Memorial Sloan Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 14
Yi-Mi Wu
University of Michigan Medical School ann arbor
Career Start Year 1995
Number of shared co-authors 4
Woong-Yang Park
Samsung Genome Institute, Samsung Medical Center
Career Start Year 1995
Number of shared co-authors 8
Adam B Olshen
12224University of California san francisco
Career Start Year 1993
Number of shared co-authors 13
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Career Start Year 1992
Number of shared co-authors 44
John Easton
St Jude Children's Research Hospital
Career Start Year 1991
Number of shared co-authors 20
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Career Start Year 1990
Number of shared co-authors 25
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 22
E Alejandro Sweet-Cordero
University of California San Francisco
Career Start Year 1989
Number of shared co-authors 15
Glenn M Marshall
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 1989
Number of shared co-authors 23
Jonathan R Pollack
Stanford University School of Medicine
Career Start Year 1987
Number of shared co-authors 3
Ching C Lau
Baylor College of Medicine
Career Start Year 1982
Number of shared co-authors 34
Michelle Haber
School of Clinical Medicine
Career Start Year 1973
Number of shared co-authors 29

Collaborators

Javed Khan
Center for Cancer Research, National Cancer Institute
Co-authored papers 82
Young K Song
National Cancer Institute, National Institutes of Health
Co-authored papers 36
Qing-Rong Chen
Center for Biomedical Informatics and Information Technology
Co-authored papers 20
Jack F Shern
Co-authored papers 12
John M Maris
Children's Hospital of Philadelphia
Co-authored papers 11
Stephen M Hewitt
Center for Cancer Research, National Cancer Institute
Co-authored papers 10
Sven Bilke
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 8
Seth M Steinberg
Center for Cancer Research, National Cancer Institute
Co-authored papers 8
Jaime M Guidry Auvil
National Cancer Institute
Co-authored papers 8
Frank Westermann
Co-authored papers 8
Craig C Whiteford
Kansas State University
Co-authored papers 7
Sharon J Diskin
Children's Hospital of Philadelphia
Co-authored papers 7
Malcolm A Smith
National Cancer Institute
Co-authored papers 6
Braden T Greer
National Cancer Institute
Co-authored papers 6
Daniela S Gerhard
National Cancer Institute
Co-authored papers 6
Markku Miettinen
National Cancer Institute
Co-authored papers 5
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Co-authored papers 5
Gonzalo L??pez
Children's Hospital of Philadelphia
Co-authored papers 5
Nicola Cenacchi
International Food Policy Research Institute
Co-authored papers 5
Xiaohu Zhang
National Center for Advancing Translational Sciences
Co-authored papers 4
Douglas S Hawkins
Co-authored papers 4
Arnulfo Mendoza
National Cancer Institute, National Institutes of Health
Co-authored papers 4
Chang-Gue Son
Institute of Bioscience and Integrative Medicine, Daejeon University
Co-authored papers 4
Brigitte C Widemann
Co-authored papers 4
Douglas R Stewart
Clinical Genetics Branch, National Cancer Institute
Co-authored papers 4
Udayan Guha
Co-authored papers 4
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 4
Kathleen A Calzone
National Institutes of Health, National Cancer Institute, Center for Cancer Research
Co-authored papers 4
Frank Berthold
Co-authored papers 4
Vinodh N Rajapakse
Co-authored papers 4
Release 1.2